Literature DB >> 6372394

Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients.

B Imbimbo, T Tuzi, F Porzio, L Schiavetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372394

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.

Authors:  G Aicardi; S Milani; B Imbimbo; M Vignolo; E Di Battista; R Gusmano; A Terragna; G Cordone; F Cottafava; R Coppo
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

2.  Bone loss after glucocorticoid therapy.

Authors:  V Lo Cascio; E Bonucci; B Imbimbo; P Ballanti; D Tartarotti; G Galvanini; L Fuccella; S Adami
Journal:  Calcif Tissue Int       Date:  1984-07       Impact factor: 4.333

3.  Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.

Authors:  S Balsan; D Stéru; A Bourdeau; R Grimberg; G Lenoir
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

4.  Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.

Authors:  K Olgaard; T Storm; N van Wowern; H Daugaard; M Egfjord; E Lewin; L Brandi
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

5.  Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.

Authors:  B Lund; C Egsmose; S Jørgensen; M R Krogsgaard
Journal:  Calcif Tissue Int       Date:  1987-12       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.